Advertisement

Adipose mesenchymal stromal cells (AMSC) as a base of a combined cell therapy for chronic spinal cord injury (CSCI) patients. clinical and electrophysiological response after six month of treatment

      To improve time and quality of clinical response of BEN therapy, (Cytotherapy 2006;8:202-209 and Spinal Cord, 2009;47:499-503) BM MSC have been replaced by aMSC. (MED therapy).
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Cytotherapy
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect